Autopsy report · NCT04890379

Dimethyl Fumarate for the Treatment of Intracerebral Hemorrhage

“There are no sufficient patients in the hospital.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 2

Sponsor

Xuanwu Hospital, Beijing

Sponsor type

University, hospital or other

Conditions

Intracerebral Hemorrhage

Interventions

Dimethyl fumarate; Placebo

Participants

0

Sites

1

Countries

China

Trials that died the same way

• Yinhu Qingwen Decoction for the Treatment of Mild / Common CoVID-19
  “There were no eligible patients in the paticipated centers.” (78% match in meaning)
• Hepatic Mitochondrial Function in Sepsis
  “no patients to include” (77% match in meaning)
• Use of the INAMED LAPBAND System to Reduce BMI's in Obese Renal Failure Patients
  “No patients were enrolled.” (76% match in meaning)
• Energy Expenditure and Gastric Bypass Surgery
  “no patients enrolled.” (76% match in meaning)
• Neoadjuvant Doxorubicin/Cyclophosphamide Followed by Eribulin Chemotherapy (ACE) in Operable HER2-negative Breast Cancer
  “No patients recruited.” (74% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.